Skip to content

RElapse in previously irradiated Prostate bed : a phase I/II study of stereotactic Ablative reIRradiation potentiated by Metformine (REPAIR GETUG P16)

Status
Recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2022-502642-27-00
Acronym
ICO-2020-01 REPAIR
Enrollment
44
Registered
2024-04-09
Start date
2020-11-26
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

RElapse in previously irradiated Prostate bed

Interventions

None listed

Sponsors

Institut De Cancerologie De L Ouest
Lead SponsorOTHER

Eligibility

Sex/Gender
Male
Age
18 Years to No maximum

Countries

France

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026